Advertisement
Research Article| Volume 4, ISSUE 4, P643-654, December 1984

Pituitary Tumors

  • Joan H. Howanitz
    Correspondence
    Corresponding author: Department of Pathology, UCLA School of Medicine, Center for the Health Sciences, Los Angeles, California 90024
    Affiliations
    Chief of Clinical Pathology, VA Wadsworth Medical Center and Department of Pathology, UCLA Center for the Health Sciences, Los Angeles, California
    Search for articles by this author
  • Peter J. Howanitz
    Affiliations
    Associate Director, Clinical Laboratories, Adjunct Associate Professor of Pathology, UCLA Center for the Health Sciences, Los Angeles, California
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30892-8
Pituitary Tumors
Previous ArticleForeword
Next ArticleA Fundamental Approach to the Diagnosis of Diseases of the Thyroid Gland
      This paper is only available as a PDF. To read, Please Download here.
      The most frequent pituitary neoplasm is the adenoma, which can produce signs and symptoms owing to mass effects or secretion of pituitary hormones. The authors discuss these mass effects of pituitary tumors on the endocrine system and excess hormone secretion by pituitary adenomas.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Berry R.G.
        • Caplan H.J.
        An overview of pituitary tumors.
        Ann. Clin. Lab. Sei. 1979; 9: 94-102
        • Borst G.C.
        • Burman K.D.
        Euthyroid hyperthyroxinemia.
        Ann. Intern. Med. 1983; 98: 319-366
        • Carter J.N.
        • Tyson J.E.
        • Tolis G.
        • et al.
        Prolactin-secreting tumors and hypogonadism in 22 men.
        N. Engl. J. Med. 1978; 299: 847-852
        • Clemmons D.R.
        • Van Wyk J.J.
        Factors controlling blood concentration of somatomedin C.
        Clin. Endocrinol. Metab. 1984; 13: 113-143
        • Cook D.M.
        Pituitary tumors: Diagnosis and therapy.
        CA. 1983; 33: 215-236
        • Cowden E.A.
        • Thomson J.A.
        • Doyle D.
        • et al.
        Tests of prolactin secretion in diagnosis of prolactinomas.
        Lancet. 1979; 1: 1155-1158
        • Cusick J.F.
        • Hagen T.C.
        • Findling J.W.
        Inappropriate secretion of antidiuretic hormone after transsphenoidal surgery for pituitary tumors.
        N. Engl. J. Med. 1984; 311: 36-38
        • Fluckiger E.
        • del Pozo E.
        • von Werder K.
        Prolactin.
        Physiology, Pharmacology and Clinical Findings, Berlin, Springer-Verlag1982
        • Franks S.
        • Jacobs H.S.
        Hyperprolactinemia.
        Clin. Endocrinol. Metab. 1983; 12: 641-667
        • Gharib H.
        • Carpenter P.C.
        • Scheithauer B.W.
        The spectrum of inappropriate pituitary thyrotropin secretion associated with hyperthyroidism.
        Mayo Clin. Proc. 1982; 57: 556-563
        • Gomez-Pan A.
        • Rodriguez A.
        Somatostatin and growth hormone releasing factor: Synthesis, location, metabolism, and function.
        Clin. Endocrinol. Metab. 1983; 12: 469-507
        • Harris R.E.
        • Schatz N.J.
        • Gennarelli T.
        • et al.
        Follicle-stimulating hormone-secreting pituitary adenomas: Correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery.
        J. Clin. Endocrinol. Metab. 1983; 56: 1288-1293
        • Hershon K.S.
        • Kelly W.A.
        • Shaw C.M.
        • et al.
        Prolactinomas as part of the multiple endocrine neoplastic syndrome Type 1.
        Am. J. Med. 1983; 74: 713-720
        • Hill S.A.
        • Falko J.M.
        • Wilson C.B.
        • et al.
        Thyrotropin-producing pituitary adenomas.
        J. Neurosurg. 1982; 57: 515-519
        • Kellett J.
        • Friesen H.G.
        Bromocriptine and pituitary disorders.
        Ann. Intern. Med. 1979; 90: 980-982
        • Kleinberg D.L.
        • Noel G.L.
        • Frantz A.G.
        Galactorrhea: A study of 235 cases, including 48 with pituitary tumors.
        N. Engl. J. Med. 1977; 296: 589-600
        • Klibanski A.
        • Ridgway E.C.
        • Zervas N.T.
        Pure alpha subunit—secreting pituitary tumors.
        J. Neurosurg. 1983; 59: 585-589
        • Kourides I.A.
        • Hoffman B.
        • Landon B.
        Difference in glycosylation between secreted and pituitary free α-subunit of the glycoprotein hormones.
        J. Clin. Endocrinol. Metab. 1983; 51: 1372-1377
        • Lamberton R.P.
        • Jackson I.M.D.
        Investigation of hypothalamic-pituitary disease.
        Clin. Endocrinol. Metab. 1983; 12: 509-534
        • Malarkey W.B.
        • Goodenow T.J.
        • Lanese R.R.
        Diurnal variation of prolactin secretion differentiates pituitary tumors from the primary empty sella syndrome.
        Am. J. Med. 1980; 69: 886-890
        • McComb D.J.
        • Ryan N.
        • Horvath E.
        • et al.
        Subclinical adenomas of the human pituitary.
        Arch. Pathol. Lab. Med. 1983; 107: 488-491
        • Molitch M.E.
        • Reichlin S.
        The amenorrhea, galactorrhea, and hyperprolactinemia syndromes.
        in: Stollerman G.H. Advances in internal medicine. Year Book Medical Publishers, Chicago1980
        • Mukai K.
        Pituitary adenomas. Immunocytochemical study of 150 tumors with clinico-pathologic correlation.
        Cancer. 1983; 52: 648-653
        • Nabarro J.D.N.
        Pituitary prolactinomas.
        Clin. Endocrinol. 1982; 17: 129-155
        • Nicolis G.L.
        • Modhi G.
        • Gabrilove J.L.
        Gonadotropin producing pituitary adenomas. A case report and review of the literature.
        Mt. Sinai J. Med. 1982; 49: 297-304
        • Rees L.H.
        Prolactin.
        in: Alberti K.G.M.M. Price C.P. Recent Advances in Clinical Biochemistry. Edinburgh, Churchill-Livingstone1981
        • Robinson A.G.
        • Nelson P.B.
        Prolactinomas in women: Current therapies.
        Ann. Intern. Med. 1983; 99: 115-118
        • Rogol A.D.
        • Eastman R.C.
        Prolactin and pituitary tumors.
        Am. J. Med. 1979; 66: 547-548
        • Roman S.H.
        • Goldstein M.
        • Kourides I.A.
        • et al.
        The luteinizing hormone-releasing hormone (LHRH) agonist (D-Trp6-Pro9-NET) LHRH increased rather than lower LH and α-subunit levels in a patient with an LH-secreting pituitary tumor.
        J. Clin. Endocrinol. Metab. 1984; 58: 313-319
        • Rose L.H.
        • Williams G.H.
        • Jagger P.I.
        • et al.
        The 48-hour adenocorticotrophin infusion test for adenocortical insufficiency.
        Ann. Intern. Med. 1970; 73: 49-59
        • Schlechte J.
        • Sherman B.
        • Halmi W.
        • et al.
        Prolactin-secreting pituitary tumors in amenorrheic women: A comprehensive study.
        Endocr. Rev. 1980; 1: 295-308
        • Schriock E.A.
        • Lustig R.H.
        • Rosenthal S.M.
        • et al.
        Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: Evidence for hypothalamic GRH deficiency.
        J. Clin. Endocrinol. Metab. 1984; 58: 1043-1049
        • Smallridge R.C.
        • Smith C.E.
        Hyperthyroidism due to thyrotropin-secreting pituitary tumors. Diagnostic and therapeutic considerations.
        Arch. Intern. Med. 1983; 143: 503-507

      34. Solback, H. G., Wiegelmann, W., Kley, H. K., et al.: Endocrine elevation of pituitary insufficiency. In Fahlbush, R. (ed): Treatment of Pituitary Adenomas. PSG Publishing Co., 1978.

        • Trouillas J.
        • Girod C.
        • Sassolas G.
        • et al.
        A human β-endorphin pituitary adenoma.
        J. Clin. Endocrinol. Metab. 1984; 58: 242-249
        • Veldhuis J.D.
        • Hammond J.M.
        Endocrine function after spontaneous infarction of the human pituitary: Reports, review, and reappraisal.
        Endocr. Rev. 1984; 1: 100-106
        • Wass J.A.H.
        • Besser G.M.
        The medical management of hormone-secreting tumors of the pituitary.
        Ann. Rev. Med. 1983; 34: 283-294
        • Yamomoto K.
        • Saito K.
        • Takai T.
        • et al.
        Visual field defects and pituitary enlargement in primary hypothyroidism.
        J. Clin. Endocrinol. Metab. 1983; 57: 283-287
        • Zervas N.T.
        • Martin J.B.
        Current concepts in cancer.
        Management of hormone-secreting pituitary adenomas. 1980; 302: 210-214

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30892-8

      Copyright

      © 1984 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX